Data as of Nov 12, 2026.
DRKY vs INK: Dividend Yield & Total Return
Return, fees and overlap, side by side.
Pair scorecard
INK costs 0.60 points a year less.
Points (pts) are percentage points.
| Measure | DRKY | INK |
|---|---|---|
| Paid and earned | ||
| Total return, 1 year | +3.8% | not published |
| Price change | fell 10.8% (1 year) | fell 1.2% (since Nov 4, 2026) |
| Return of capital, issuer estimate | 100% of the Oct 27, 2026 payment | |
| Against its benchmark | ||
| Benchmark | S&P 500, measured through SPY | not published |
| Cost and size | ||
| Expense ratio | 0.95% | 0.35% |
| Net assets, DRKY as of Nov 10, 2026 and INK as of Nov 11, 2026 | $18m | $5.3m |
| Holdings | ||
| Holdings in common | not published | |
8.2 pts behind SPY
DRKY over 1 year: paid 14.4%, price −10.8%, total +3.8%, SPY +12.0%, −8.2 pts. Data to Nov 12, 2026.
SPY
+12.0%
DRKY
+3.8%
14.4% as cash
8.2 pts behind SPY
Total return, distributions reinvested
8.2 pts behind SPY
DRKY over 1 year: paid 14.4%, price −10.8%, total +3.8%, SPY +12.0%, −8.2 pts. Data to Nov 12, 2026.
SPY
+12.0%
DRKY
+3.8%
8.2 pts behind SPY
14.4% of it arrived as cash. Total return, distributions reinvested. DRKY over 1 year: paid 14.4%, price −10.8%, total +3.8%, SPY +12.0%, −8.2 pts. Data to Nov 12, 2026.
Data to Nov 12, 2026.Not measured
INK since launch: paid 0.0%, price −1.2%, total −1.2%, not measured against a benchmark. Data to Nov 12, 2026.
INK
−1.2%
Total return, distributions reinvested
Not measured
INK since launch: paid 0.0%, price −1.2%, total −1.2%, not measured against a benchmark. Data to Nov 12, 2026.
INK
−1.2%
0.0% of it arrived as cash. Both charts share one scale, with zero at the line. INK since launch: paid 0.0%, price −1.2%, total −1.2%, not measured against a benchmark. Data to Nov 12, 2026.
Data to Nov 12, 2026.Side by side
As of Nov 12, 2026. Source: ETFIQ. Cash paid: distributions over the window, as a share of the starting price. Payout rate: the latest payment, annualized, over today’s price.
Window by window
| Total return | Cash paid | Against the benchmark | ||||
|---|---|---|---|---|---|---|
| Window | DRKY | INK | DRKY | INK | DRKY | INK |
| 3 months | −6.4% | – | 3.8% | – | −3.9 pts | – |
| 6 months | +4.1% | – | 7.8% | – | +2.4 pts | – |
| 1 year | +3.8% | – | 14.4% | – | −8.2 pts | – |
| Since launchNot the same days: DRKY Oct 2025 · INK Nov 2026 | +13.2% | −1.2% | 16.8% | 0.0% | −0.5 pts | not measured |
– means no data for this window. Open this comparison in the app →
DRKY
Over the year to Nov 12, 2026, DRKY paid 14.4% of its starting value in cash distributions while its price fell 10.8%. With every distribution reinvested, the fund returned +3.8%. S&P 500 (SPY) returned +12.0% over the same days, so a holder was behind by 8.2 pts. At its price on Nov 12, 2026 the latest distribution annualizes to 16.1%, paid monthly. VistaShares estimates that 100% of the distribution paid Oct 27, 2026 was a return of capital (its 19a-1 notice). That is a tax label, not a measure of erosion.
INK
Over the period from its first trade on Nov 4, 2026 to Nov 12, 2026, INK paid 0.0% of its starting value in cash distributions while its price fell 1.2%. With every distribution reinvested, the fund returned −1.2%.
Questions people ask
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Every number is an ETFIQ calculation with distributions reinvested.
Cite this pageCitation, APA and Markdown
ETFIQ, DRKY against INK, data as of Nov 12, 2026. https://etfiq.com/compare/income/drky-vs-ink
ETFIQ. (Nov 12, 2026). DRKY against INK. Retrieved from https://etfiq.com/compare/income/drky-vs-ink
[DRKY against INK (ETFIQ, Nov 12, 2026)](https://etfiq.com/compare/income/drky-vs-ink)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.
DRKY and INK both write options for income.